Report Categories Report Categories

Report Categories

industry Category

All

Total: 10 records, 1 pages

Global Human Albumin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

new_biaoQian Human Albumin

According to our (Global Info Research) latest study, the global Human Albumin market size was valued at USD 5280.6 million in 2023 and is forecast to a readjusted size of USD 7093.6 million by 2030 with a CAGR of 4.3% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Human Albumin Solution Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 21 Jan 2024

date Medical Care

new_biaoQian Human Albumin Solution

According to our (Global Info Research) latest study, the global Human Albumin Solution market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

Add To Cart

Add To Cart

Global Human Albumin Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 21 Jan 2024

date Pharma & Healthcare

new_biaoQian Human Albumin Injection

According to our (Global Info Research) latest study, the global Human Albumin Injection market size was valued at USD 407.5 million in 2023 and is forecast to a readjusted size of USD 565.2 million by 2030 with a CAGR of 4.8% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Recombinant Human Albumin Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 04 Jan 2024

date Medical Care

new_biaoQian Recombinant Human Albumin

According to our (Global Info Research) latest study, the global Recombinant Human Albumin market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

Add To Cart

Add To Cart

Global Human Albumin Supply, Demand and Key Producers, 2023-2029

date 16 Jan 2023

date Pharma & Healthcare

new_biaoQian Human Albumin

Albumin-based therapies such as Idelvion (CSL654 rIX-FP) by CSL Behring received marketing approval from the US FDA in March 2016 and from the EMA in May 2016. Apart from these, Albutropin (TV-1106) by Teva Pharmaceuticals, Ampion by Ampio Pharmaceuticals, and Albutein by Grifols (for Alzheimer's disease) are expected to enter the market during the forecast period.

USD4480.00

Add To Cart

Add To Cart

Global Human Albumin Solution Supply, Demand and Key Producers, 2023-2029

date 28 Apr 2023

date Medical Care

new_biaoQian Human Albumin Solution

The global Human Albumin Solution market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

Add To Cart

Add To Cart

Global Human Albumin Solution Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 28 Apr 2023

date Medical Care

new_biaoQian Human Albumin Solution

According to our (Global Info Research) latest study, the global Human Albumin Solution market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

USD3480.00

Add To Cart

Add To Cart

Global Human Albumin Injection Supply, Demand and Key Producers, 2023-2029

date 28 Apr 2023

date Pharma & Healthcare

new_biaoQian Human Albumin Injection

The global Human Albumin Injection market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

Add To Cart

Add To Cart

Global Human Albumin Injection Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 28 Apr 2023

date Pharma & Healthcare

new_biaoQian Human Albumin Injection

According to our (Global Info Research) latest study, the global Human Albumin Injection market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

USD3480.00

Add To Cart

Add To Cart

Global Recombinant Human Albumin Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 14 Jan 2023

date Medical Care

new_biaoQian Recombinant Human Albumin

Recombinant human albumin (rHA) is a highly purified animal-, virus-, and prion-free product developed as an alternative to human serum albumin (HSA), to which it is structurally equivalent.

USD3480.00

Add To Cart

Add To Cart

industry 02 Jan 2024

industry Pharma & Healthcare

new_biaoQian Human Albumin

According to our (Global Info Research) latest study, the global Human Albumin market size was valued at USD 5280.6 million in 2023 and is forecast to a readjusted size of USD 7093.6 million by 2030 with a CAGR of 4.3% during review period.

USD3480.00

addToCart

Add To Cart

industry 21 Jan 2024

industry Medical Care

new_biaoQian Human Albumin Solution

According to our (Global Info Research) latest study, the global Human Albumin Solution market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

addToCart

Add To Cart

industry 21 Jan 2024

industry Pharma & Healthcare

new_biaoQian Human Albumin Injection

According to our (Global Info Research) latest study, the global Human Albumin Injection market size was valued at USD 407.5 million in 2023 and is forecast to a readjusted size of USD 565.2 million by 2030 with a CAGR of 4.8% during review period.

USD3480.00

addToCart

Add To Cart

industry 04 Jan 2024

industry Medical Care

new_biaoQian Recombinant Human Albumin

According to our (Global Info Research) latest study, the global Recombinant Human Albumin market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

addToCart

Add To Cart

industry 16 Jan 2023

industry Pharma & Healthcare

new_biaoQian Human Albumin

Albumin-based therapies such as Idelvion (CSL654 rIX-FP) by CSL Behring received marketing approval from the US FDA in March 2016 and from the EMA in May 2016. Apart from these, Albutropin (TV-1106) by Teva Pharmaceuticals, Ampion by Ampio Pharmaceuticals, and Albutein by Grifols (for Alzheimer's disease) are expected to enter the market during the forecast period.

USD4480.00

addToCart

Add To Cart

industry 28 Apr 2023

industry Medical Care

new_biaoQian Human Albumin Solution

The global Human Albumin Solution market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

addToCart

Add To Cart

industry 28 Apr 2023

industry Medical Care

new_biaoQian Human Albumin Solution

According to our (Global Info Research) latest study, the global Human Albumin Solution market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

USD3480.00

addToCart

Add To Cart

industry 28 Apr 2023

industry Pharma & Healthcare

new_biaoQian Human Albumin Injection

The global Human Albumin Injection market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

addToCart

Add To Cart

industry 28 Apr 2023

industry Pharma & Healthcare

new_biaoQian Human Albumin Injection

According to our (Global Info Research) latest study, the global Human Albumin Injection market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

USD3480.00

addToCart

Add To Cart

industry 14 Jan 2023

industry Medical Care

new_biaoQian Recombinant Human Albumin

Recombinant human albumin (rHA) is a highly purified animal-, virus-, and prion-free product developed as an alternative to human serum albumin (HSA), to which it is structurally equivalent.

USD3480.00

addToCart

Add To Cart